exocad releases new DentalCAD 2.2 Valletta - largest expansion of capabilities in company#s history

Food and Healthcare Press Releases Wednesday April 11, 2018 14:30
DARMSTADT, Germany--11 Apr--PRNewswire/InfoQuest

exocad GmbH recently announced the availability of its new release exocad DentalCAD 2.2 Valletta. With more than 30 new features, as well as enhancements to over 130 existing functionalities, the Valletta release represents the largest expansion of capabilities in exocad's history.

It also marks the introduction of exocad's new release naming scheme, where the company names major software releases after culturally important cities. This year's release is named after the 2018 European Capital of Culture.

"We are delighted to announce the release of DentalCAD 2.2 Valletta and energized about the new possibilities it presents for dental professionals," said Tillmann Steinbrecher, CEO. "This release, as always, is very much a collaborative effort between exocad and its customers. The product evolves as a result of invaluable feedback and feature requests we receive from users, enabling us to drive innovation and continuously set the industry standard in digital dentistry excellence."

Major highlights of the new release are among others:
  • dentalshare webview: True 3D preview links that work in a web browser and on your mobile device
  • Faster interaction thanks to many usability and performance improvements
  • Many new hotkeys for frequently used functions
  • New Contact Point tools: Smarter approximal adaptation, easy editing with Disc Cutter
  • Simplified nesting in CAD (Production Blank Selection) for CAM export, multi-layered blank rendering with TruSmile support
  • New HD tooth library with natural and aesthetically pleasing tooth set
  • Articulator: Free selection of guidance surface in articulator movement
  • Model Creator: Implant models with gingiva mask and individual insertion directions for dies
  • Improved rendering of textured/colored scans from intra-oral and face scanners
  • Option to display additional interactive cut views
All users who already have an update contract will be able to use the new release.
About exocad GmbH

exocad GmbH (exocad.com) is a dynamic and innovative software company committed to expanding the possibilities of digital dentistry and providing OEMs (Original Equipment Manufacturers) with flexible, reliable, and easy-to-use CAD/CAM software for dental labs and dental practices. exocad software has been chosen by leading OEMs worldwide for integration into their dental CAD/CAM offerings, and thousands of exocad DentalCAD licenses are sold each year. For more information and a list of exocad reseller partners, please visit exocad.com.

Photo - https://mma.prnewswire.com/media/664934/exocad_GmbH_Valetta.jpg

Latest Press Release

Medical Device Manufacturer Advant Medical Celebrates Its 25th Anniversary

Advant is a successful medical device manufacturer with corporate offices located in Galway, Ireland. For a quarter of a century, Advant has seen significant growth and development expanding into two locations in Ireland, Mexico and Costa Rica. With over...

Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Board

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in...

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the...

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and...

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Related Topics